Primary Record
fumagillin
- In stock
- 8,343 g
- Purity
- 98.9 %
- CAS
- 23110-15-8
Compound Identifiers & Properties
- CAS
- 23110-15-8
- PubChem CID
- 12015870
- SMILES
- CC(=CC[C@@H]1[C@@](O1)(C)[C@@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)OC)C
- Canonical SMILES
- CO[C@H]1[C@@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2
Names & Synonyms
- fumagillin
- Amebacillin
- Fumagilina
- Fumagillina
- Fumagilline
- Fumagillinum
- Fugillin
- Fugilin
- Fumidil
- Fumagillin DCH
- Amebacilin;NSC9168
- Fumagillina [DCIT]
- CT-100, CisThera
- Fumagilina [INN-Spanish]
- Fumagilline [INN-French]
- Fumagillinum [INN-Latin]
- D0X7LY
- Fumagillin [BAN:DCF:INN]
- Fumagillin [INN:BAN:DCF]
- CCRIS 9025
- C26H34O7
- SCHEMBL29373922
- UNII-7OW73204U1
- CT-100
- HMS2089D13
- NSC 9168
- EINECS 245-433-8
- MFCD03990453
- ZINC13816340
- C26-H34-O7
- NCGC00186638-01
- 23110-15-8
- V0356
- U 5762
- AB01275456-01
- SR-05000001458
- SR-05000001458-1
- SR-05000001458-2
- (2E,4E,6E,8E)-10-[[(3R,4R,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl]oxy]-10-oxodeca-2,4,6,8-tetraenoic acid
- PAI-1 modulator (humanized antibody, kidney disease), CisThera
- Plasminogen activator inhibitor-1 modulator (humanized antibody, kidney disease), CisThera
- (2E,4E,6E,8E)-10-[[(3R,4R,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl]oxy]-10-oxo-deca-2,4,6,8-tetraenoic acid
- 2,4,6,8-Decatetraenedioic acid, mono[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] ester, (2E,4E,6E,8E)-
- 2,4,6,8-Decatetraenedioic acid, mono[5-methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] ester, [3R-[3.alpha.,4.alpha.(2R*,3R*),5.beta.,6.beta.(all-E)]]-
- H-3